Guangzhou Sino-Israel Biotech Investment Fund (GIBF)

Venture Capital Tel Aviv-Yafo, Israel Est. 2016
Visit website ↗
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

GIBF is a Sino-Israeli investment fund established in 2016 and currently invests out of its second fund of $300m. With a ticket size of $5-20m, we are looking to invest in innovative biotech companies around the globe. Our focus is on drug development and delivery companies that are at clinical or approaching clinical stages of development and aspire to establish activities in China. The first fund of GIBF ($100m) has completed the investment period in 2021, investing in 12 medical device and digital health companies.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary investment focus of Guangzhou Sino-Israel Biotech Investment Fund (GIBF)?
GIBF focuses on innovative biotech companies globally, specifically those in drug development and delivery at clinical or near-clinical stages, with aspirations to establish activities in China. Their ticket size ranges from $5-20 million.
How many funds has GIBF raised and what are their sizes?
GIBF has raised two funds. Their first fund was $100 million, and they are currently investing out of their second fund, which is $300 million.
When did GIBF complete the investment period for its first fund?
GIBF completed the investment period for its first fund ($100 million) in 2021.
What types of companies did GIBF's first fund invest in?
The first fund of GIBF invested in 12 medical device and digital health companies.
Can you name a notable recent investment by GIBF and its amount?
According to startupim data, GIBF led an investment of $10 million in Nectin Therapeutics in May 2024.
Which sectors does GIBF primarily invest in?
GIBF exclusively invests in the Health Tech & Life Sciences sector, as indicated by their portfolio and rounds per sector data.
Has GIBF acted as a lead investor in its portfolio companies?
Yes, GIBF has acted as a lead investor in several rounds, including for Nectin Therapeutics in May 2024, CoreBone in October 2021, and CorNeat Vision in August 2021.
What is the earliest recorded investment date for GIBF?
According to startupim data, GIBF's first recorded investment was in Neurotech Solutions in March 2018.